CollPlant Biotechnologies Crecimiento futuro
Future controles de criterios 2/6
Se prevé un crecimiento anual de los beneficios y los ingresos de CollPlant Biotechnologies de 65% y 40% respectivamente, mientras que el BPA crecerá en un 67.8% al año.
Información clave
65.0%
Tasa de crecimiento de los beneficios
67.8%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 28.4% |
| Tasa de crecimiento de los ingresos | 40.0% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 21 Aug 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow
Aug 20
We're Interested To See How CollPlant Biotechnologies (NASDAQ:CLGN) Uses Its Cash Hoard To Grow
Feb 03Is CollPlant Biotechnologies (NASDAQ:CLGN) In A Good Position To Deliver On Growth Plans?
Nov 02CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) Shares Lagging The Industry But So Is The Business
Sep 06Here's Why We're Watching CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation
Jul 14Here's Why We're Not Too Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation
Mar 02Companies Like CollPlant Biotechnologies (NASDAQ:CLGN) Are In A Position To Invest In Growth
Nov 10CollPlant Non-GAAP EPS of -$0.36, revenue of $0.07M
Aug 25We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth
Jul 22CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 22CollPlant Biotechnologies - A Cheap, Game-Changing Bio-Printing Platform Company
Aug 05Why We Think Shareholders May Be Considering Bumping Up CollPlant Biotechnologies Ltd.'s (NASDAQ:CLGN) CEO Compensation
Jul 29The Strong Earnings Posted By CollPlant Biotechnologies (NASDAQ:CLGN) Are A Good Indication Of The Strength Of The Business
Jun 09Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2026 | 20 | 0 | 1 | 1 | 2 |
| 12/31/2025 | 13 | -6 | -6 | -6 | 2 |
| 12/31/2024 | 2 | -17 | -17 | -16 | 2 |
| 6/30/2024 | 1 | -17 | -4 | -3 | N/A |
| 3/31/2024 | 11 | -7 | -3 | -3 | N/A |
| 12/31/2023 | 11 | -7 | -4 | -3 | N/A |
| 9/30/2023 | 11 | -7 | -5 | -4 | N/A |
| 6/30/2023 | 11 | -7 | -15 | -14 | N/A |
| 3/31/2023 | 1 | -17 | -15 | -14 | N/A |
| 12/31/2022 | 0 | -17 | -15 | -14 | N/A |
| 9/30/2022 | 1 | -16 | -14 | -13 | N/A |
| 6/30/2022 | 1 | -15 | -14 | -12 | N/A |
| 3/31/2022 | 1 | -14 | -14 | -12 | N/A |
| 12/31/2021 | 16 | 0 | 1 | 3 | N/A |
| 9/30/2021 | 16 | 1 | 2 | 3 | N/A |
| 6/30/2021 | 20 | 5 | 7 | 8 | N/A |
| 3/31/2021 | 20 | 6 | 9 | 9 | N/A |
| 12/31/2020 | 6 | -6 | -5 | -4 | N/A |
| 9/30/2020 | 6 | -7 | -5 | -4 | N/A |
| 6/30/2020 | 3 | -11 | -8 | -7 | N/A |
| 3/31/2020 | 2 | -11 | -8 | -7 | N/A |
| 12/31/2019 | 2 | -11 | -7 | -6 | N/A |
| 9/30/2019 | 6 | -6 | -2 | -1 | N/A |
| 6/30/2019 | 6 | -6 | -2 | -1 | N/A |
| 3/31/2019 | 5 | -4 | -2 | -1 | N/A |
| 12/31/2018 | 5 | -6 | -2 | -1 | N/A |
| 9/30/2018 | 1 | -6 | -7 | -6 | N/A |
| 6/30/2018 | 1 | -6 | -6 | -6 | N/A |
| 3/31/2018 | 1 | -7 | N/A | -5 | N/A |
| 12/31/2017 | 0 | -6 | N/A | -5 | N/A |
| 9/30/2017 | 0 | -6 | N/A | -5 | N/A |
| 6/30/2017 | 0 | -7 | N/A | -5 | N/A |
| 3/31/2017 | 0 | -7 | N/A | -5 | N/A |
| 12/31/2016 | 0 | -7 | N/A | -5 | N/A |
| 9/30/2016 | 0 | -7 | N/A | -5 | N/A |
| 6/30/2016 | N/A | -7 | N/A | -5 | N/A |
| 3/31/2016 | N/A | -6 | N/A | -5 | N/A |
| 12/31/2015 | N/A | -5 | N/A | -4 | N/A |
| 9/30/2015 | N/A | -4 | N/A | -4 | N/A |
| 6/30/2015 | N/A | -4 | N/A | -4 | N/A |
| 3/31/2015 | N/A | -3 | N/A | -3 | N/A |
| 12/31/2014 | N/A | -3 | N/A | -3 | N/A |
| 9/30/2014 | N/A | -4 | N/A | -4 | N/A |
| 6/30/2014 | N/A | -4 | N/A | -4 | N/A |
| 3/31/2014 | N/A | -4 | N/A | -4 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: Se prevé que CLGN siga sin ser rentable en los próximos 3 años.
Beneficios vs. Mercado: Se prevé que CLGN siga sin ser rentable en los próximos 3 años.
Beneficios de alto crecimiento: Se prevé que CLGN siga sin ser rentable en los próximos 3 años.
Ingresos vs. Mercado: Se prevé que los ingresos (40% al año) de CLGN crezcan más rápidamente que los del mercado US (9% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos (40% al año) de CLGN crezcan más rápidamente que un 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CLGN se prevé que sea elevada dentro de 3 años.